# Wise healthcare Medical Technology (Shanghai) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wise-healthcare-medical-technology-shanghai-co

- Industry: Software
- Headquarters: Beijing, China
- Website: www.wiseltd.cn
- Latest round: Series A (Apr 26, 2022)
- Investors on record: 1

## About

Established in 2018 and based in Beijing, China, the company has built a real-world oncology data platform to provide clinical research services for pharmaceutical companies based on a real-world research framework. The company joined hands with the Chinese Society of Clinical Oncology (CSCO) in the early stage of its establishment to initiate the public benefit China Primary Liver Cancer Clinical Registry Survey (CLCS) real-world research project, which now covers 5,000+ core experts, 250,000+ tumor patient diagnosis, treatment and prognosis data, and enrolls more than 100 large hospitals to participate. The company's team consists of the medical department, follow-up service department, technology research and development department and marketing operations Department. The founder, Mr. Hong Zhu, has a background in bioinformatics.

The company has built the WisePHR data management system to provide oncology digital products and service solutions for the pharmaceutical enterprise side, patient side and medical institution side, mainly for liver cancer, while laying out many cancer types such as bile duct cancer, pancreatic cancer and gastric cancer. The company has also developed digital therapy products, a software program-driven, evidence-based intervention program to treat, manage and prevent disease.

## Funding rounds

- Series A, Apr 26, 2022 — Sinopharm-CICC Capital

## Investors

- Sinopharm-CICC Capital (https://capitalatlas.ai/funds/sinopharm-cicc-capital) — Series A